• Vol. 29 No. 6, 727–731
  • 15 November 2000

Transurethral Alprostadil for the Treatment of Erectile Dysfunction: Results of a Multicentre Trial

76



76 Views
15 Downloads

Download PDF

ABSTRACT

Introduction: The incidence of erectile dysfunction (ED) has been shown to increase significantly in Singaporean male population. Thus, this prospective study (no controls) assessed the clinical efficacy and safety of a medicated urethral system for erection (MUSE) in Singaporean male patients with a known history of ED.

Subjects and Method: Eighty-six men with a mean age of 55.7 years with differential causes of ED were administered with MUSE in the clinic with a titration adjustment of 4 possible dose regimes (125, 250, 500 and 1000 mcg) till efficacy is achieved. Subsequently, patients were subjected to home treatment for a duration of 3 months.

Results: Sixty per cent of in-clinic patients exhibited good responses and were given MUSE for home treatment. The efficacy rate for home treatment was 86%. Overall, the patients (n = 86) had a 51.2% success rate in achieving satisfactory sexual intercourse. Diabetic and psychogenic patients were noted to respond well to MUSE. No severe adverse events were found in this study.

Conclusion: MUSE showed to be a safe, less invasive, well-tolerated and efficient alternative treatment for ED in Singaporean men.


As the population is growing older and the society getting more affluent, people are aiming for a better quality of life. This has resulted in greater awareness of erectile dysfunction (ED), thus increasing the number of patients approaching the doctor for consultation.

This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.